SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-059020
Filing Date
2021-04-30
Accepted
2021-04-30 16:12:25
Documents
6
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212548-2_def14a.htm DEF 14A 863741
2 GRAPHIC lg_avadelpharm-4c.jpg GRAPHIC 46177
3 GRAPHIC tm212548d2-prxy_avadel14c.jpg GRAPHIC 630615
4 GRAPHIC tm212548d2-prxy_avadel1bw.jpg GRAPHIC 248278
5 GRAPHIC tm212548d2-prxy_avadel24c.jpg GRAPHIC 341238
6 GRAPHIC tm212548d2-prxy_avadel2bw.jpg GRAPHIC 217583
  Complete submission text file 0001104659-21-059020.txt   2892954
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37977 | Film No.: 21878111
SIC: 2834 Pharmaceutical Preparations